Synapse - Danny Khalil

Search Within

Danny Nejad Khalil

Results (65)

Stereotactic ablative radiation for pancreatic cancer on a 1.5 Telsa magnetic resonance-linac system

Journal Article

Tringale, K. R.; Tyagi, N.; Reyngold, M.; Romesser, P. B.; Wu, A.; O'Reilly, E. M.; Varghese, A. M.; Godoy Scripes, P.; Khalil, D. N.; Park, W.; more...
Physics and Imaging in Radiation Oncology (2022)

Fulltext@MSK | Save

Transcriptomic profiling to identify subsets of immune hot locally advanced rectal adenocarcinomas with favorable outcomes after neoadjuvant treatment

Meeting Abstract

Sanchez Vega, F.; Chatila, W. K.; Kim, J. K.; Walch, H. S.; Marco, M.; Chen, C. T.; Wu, F.; Khalil, D.; Ganesh, K.; Qu, X.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Nivolumab (NIVO) and drug eluting bead transarterial chemoembolization (deb-TACE): Updated results from an ongoing phase 1 study of patients (pts) with liver limited hepatocellular carcinoma (HCC)

Meeting Abstract

Harding, J. J.; Yarmohammadi, H.; Reiss, K. A.; Chou, J. F.; Capanu, M.; Do, R. K. G.; Khalil, D.; El Dika, I. H.; Ferrer, C. S.; Heffernan, O.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Mouse characteristics that affect establishing xenografts from hepatocellular carcinoma patient biopsies in the United States

Journal Article

Zou, C.; El Dika, I.; Vercauteren, K. O. A.; Capanu, M.; Chou, J.; Shia, J.; Pilet, J.; Quirk, C.; Lalazar, G.; Andrus, L.; more...
Cancer Medicine (2022)

Fulltext@MSK | Save

An exploratory study of nivolumab (nivo) with or without ipilimumab (ipi) according to the percentage of tumoral CD8 cells in advanced metastatic cancer

Meeting Abstract

Tsimberidou, A. M.; Drakaki, A.; Khalil, D.; Kummar, S.; Hodi, F. S.; Oh, D. Y.; Cabanski, C. R.; Tezlaff, M.; LaVallee, T.; Spasic, M.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

FORTITUDE phase I study of NG-350A, a novel tumour-selective adenoviral vector expressing an anti-CD40 agonist antibody: Monotherapy dose escalation results

Meeting Abstract

Naing, A.; Rosen, L.; Camidge, R. D.; Khalil, D.; Davies, J.; Miles, D.; Patel, M.; Cockle, P.; Champion, B.; Krige, D.; more...
Annals of Oncology (2021)

Fulltext@MSK | Save

Association of ablative radiation therapy with survival among patients with inoperable pancreatic cancer

Journal Article

Reyngold, M.; O'Reilly, E. M.; Varghese, A. M.; Fiasconaro, M.; Zinovoy, M.; Romesser, P. B.; Wu, A.; Hajj, C.; Cuaron, J. J.; Tuli, R.; more...
JAMA Oncology (2021)

Fulltext@MSK | Save

Phase II single-arm study of durvalumab and tremelimumab with concurrent radiotherapy in patients with mismatch repair-proficient metastatic colorectal cancer

Journal Article

Segal, N. H.; Cercek, A.; Ku, G.; Wu, A. J.; Rimner, A.; Khalil, D. N.; Reidy-Lagunes, D.; Cuaron, J.; Yang, T. J.; Weiser, M. R.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

CDX1140-01, a phase 1 dose-escalation/expansion study of CDX-1140 alone (part 1) and in combination with CDX-301 (part 2) or pembrolizumab (part 3)

Meeting Abstract

Sanborn, R.; Hauke, R.; Gabrail, N.; O'Hara, M.; Bhardwaj, N.; Bordoni, R.; Gordon, M.; Khalil, D.; Abdelrahim, M.; Marron, T.; more...
Journal for ImmunoTherapy of Cancer (2020)

Fulltext@MSK | Save

Phase Ib study of enzalutamide with or without sorafenib in patients with advanced hepatocellular carcinoma

Journal Article

Harding, J. J.; Kelley, R. K.; Tan, B.; Capanu, M.; Do, G. K.; Shia, J.; Chou, J. F.; Ferrer, C. S.; Boussayoud, C.; Muenkel, K.; more...
The Oncologist (2020)

Fulltext@MSK | Save